Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (251-260 of 355) with videos related to

Pageof 36
Sort By:
Cancer Research|March 18, 2004
Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cellsJose R Conejo-Garcia, Fabian Benencia, Maria C Courreges, et al.
The Journal of Clinical Investigation|August 16, 2013
Predicting time to ovarian carcinoma recurrence using protein markersJi-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, et al.
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironmentAndrea R Hagemann, Mark Cadungog, Ian S Hagemann, et al.
Journal of Translational Medicine|December 17, 2009
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18Ioannis Alagkiozidis, Andrea Facciabene, Carmine Carpenito, et al.
Cancer Immunology, Immunotherapy : CII|October 25, 2011
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remissionChristina S Chu, Jean Boyer, Daniel S Schullery, et al.
Oncoimmunology|January 27, 2017
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality riskElise P Salerno, Davide Bedognetti, Ileana S Mauldin, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2018
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b TrialFernanda G Herrera, Massimo Valerio, Dominik Berthold, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 9, 2008
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 lossBlaise Clarke, Anna V Tinker, Cheng-Han Lee, et al.
Cytotherapy|March 18, 2025
DNA-dependent protein kinase inhibitors PI-103 and samotolisib augment CRISPR/Cas9 knock-in efficiency in human T cellsEmina Džafo, Morteza Hafezi, Greta Maria Paola Giordano Attianese, et al.
Pageof 36

Showing results (251-260 of 355) with videos related to

Sort By:
Pageof 36
Cancer Research|March 18, 2004
Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cellsJose R Conejo-Garcia, Fabian Benencia, Maria C Courreges, et al.
The Journal of Clinical Investigation|August 16, 2013
Predicting time to ovarian carcinoma recurrence using protein markersJi-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, et al.
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironmentAndrea R Hagemann, Mark Cadungog, Ian S Hagemann, et al.
Journal of Translational Medicine|December 17, 2009
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18Ioannis Alagkiozidis, Andrea Facciabene, Carmine Carpenito, et al.
Cancer Immunology, Immunotherapy : CII|October 25, 2011
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remissionChristina S Chu, Jean Boyer, Daniel S Schullery, et al.
Oncoimmunology|January 27, 2017
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality riskElise P Salerno, Davide Bedognetti, Ileana S Mauldin, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2018
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b TrialFernanda G Herrera, Massimo Valerio, Dominik Berthold, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 9, 2008
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 lossBlaise Clarke, Anna V Tinker, Cheng-Han Lee, et al.
Cytotherapy|March 18, 2025
DNA-dependent protein kinase inhibitors PI-103 and samotolisib augment CRISPR/Cas9 knock-in efficiency in human T cellsEmina Džafo, Morteza Hafezi, Greta Maria Paola Giordano Attianese, et al.
Pageof 36